133 related articles for article (PubMed ID: 11325817)
1. A genetically tractable model of human glioma formation.
Rich JN; Guo C; McLendon RE; Bigner DD; Wang XF; Counter CM
Cancer Res; 2001 May; 61(9):3556-60. PubMed ID: 11325817
[TBL] [Abstract][Full Text] [Related]
2. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.
Sonoda Y; Ozawa T; Hirose Y; Aldape KD; McMahon M; Berger MS; Pieper RO
Cancer Res; 2001 Jul; 61(13):4956-60. PubMed ID: 11431323
[TBL] [Abstract][Full Text] [Related]
3. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
MacKenzie KL; Franco S; Naiyer AJ; May C; Sadelain M; Rafii S; Moore MA
Oncogene; 2002 Jun; 21(27):4200-11. PubMed ID: 12082607
[TBL] [Abstract][Full Text] [Related]
4. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
6. Creation of human tumour cells with defined genetic elements.
Hahn WC; Counter CM; Lundberg AS; Beijersbergen RL; Brooks MW; Weinberg RA
Nature; 1999 Jul; 400(6743):464-8. PubMed ID: 10440377
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
[TBL] [Abstract][Full Text] [Related]
8. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
Sun B; Chen M; Hawks CL; Hornsby PJ
Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenic study on hepatocytes coexpressing SV40 with Ras.
Sun B; Chen M; Hawks C; Hornsby PJ; Wang X
Mol Carcinog; 2006 Apr; 45(4):213-9. PubMed ID: 16173010
[TBL] [Abstract][Full Text] [Related]
10. A novel human cancer culture model for the study of prostate cancer.
Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
[TBL] [Abstract][Full Text] [Related]
11. Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocortical cells and restoration of tumorigenicity by human telomerase reverse transcriptase.
Sun B; Huang Q; Liu S; Chen M; Hawks CL; Wang L; Zhang C; Hornsby PJ
Cancer Res; 2004 Sep; 64(17):6144-51. PubMed ID: 15342398
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and molecular genetic changes in malignant transformation of immortalized esophageal epithelial cells.
Shen ZY; Xu LY; Chen MH; Cai WJ; Shen J; Chen JY; Zeng Y
Int J Mol Med; 2003 Aug; 12(2):219-24. PubMed ID: 12851721
[TBL] [Abstract][Full Text] [Related]
13. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
14. A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro.
O'Hayer KM; Counter CM
Methods Enzymol; 2006; 407():637-47. PubMed ID: 16757358
[TBL] [Abstract][Full Text] [Related]
15. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
Mukai S; Kondo Y; Koga S; Komata T; Barna BP; Kondo S
Cancer Res; 2000 Aug; 60(16):4461-7. PubMed ID: 10969793
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of telomerase is related to the life span and tumorigenicity of human prostate cancer cells.
Guo C; Geverd D; Liao R; Hamad N; Counter CM; Price DT
J Urol; 2001 Aug; 166(2):694-8. PubMed ID: 11458119
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
18. A P53-dependent, telomere-independent proliferative life span barrier in human astrocytes consistent with the molecular genetics of glioma development.
Evans RJ; Wyllie FS; Wynford-Thomas D; Kipling D; Jones CJ
Cancer Res; 2003 Aug; 63(16):4854-61. PubMed ID: 12941806
[TBL] [Abstract][Full Text] [Related]
19. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
